title: The tolerability of efavirenz after nevirapine-related adverse events.
abstract: Eight patients who were infected with human immunodeficiency virus, and who had each sustained an adverse drug reaction while following a regimen including nevirapine, were switched to a regimen including efavirenz. None of the patients experienced adverse events identical to that which necessitated discontinuation of nevirapine. This study demonstrates that adverse events related to nevirapine are not a class-specific effect.
authors.affiliation: Department of GenitoUrinary Medicine, St. James' Hospital, Dublin, Ireland. gum@stjames.ie
authors.forename: S
authors.initials: S
authors.lastname: Clarke
authors.forename: P
authors.initials: P
authors.lastname: Harrington
authors.forename: M
authors.initials: M
authors.lastname: Barry
authors.forename: F
authors.initials: F
authors.lastname: Mulcahy
mesh_terms: D000328:Adult; D000368:Aged; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000139:chemically induced; D048588:Benzoxazines; D003521:Cyclopropanes; D005260:Female; D006678:HIV / Q000187:drug effects; D015658:HIV Infections / Q000188:drug therapy*; D006716:Homosexuality; D006801:Humans; D008297:Male; D008875:Middle Aged; D019829:Nevirapine / Q000009:adverse effects* / Q000627:therapeutic use; D010078:Oxazines / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine; C098320:efavirenz